A Mutation in the Cofactor-Binding Domain of 11β-Hydroxysteroid Dehydrogenase Type 2 Associated with Mineralocorticoid Hypertension1
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Renal 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) is an enzyme responsible for the peripheral inactivation of cortisol to cortisone in mineralocorticoid target tissues. Mutations in the gene encoding 11betaHSD2 cause the syndrome of apparent mineralocorticoid excess (AME), an autosomal recessive form of inherited hypertension, in which cortisol acts as a potent mineralocorticoid. The mutations reported to date have been confined to exons 3-5. Here, we describe two siblings, 1 and 2 yr old, who were diagnosed with hypokalemic hypertension and low plasma aldosterone and renin levels, indicating mineralocorticoid hypertension. Analysis of urinary steroid metabolites showed a markedly impaired metabolism of cortisol, with (tetrahydrocortisol + 5alpha-tetrahydrocortisol)/tetrahydrocortisone ratios of 40-60, and nearly absent urinary free cortisone. Although phenotypically normal, the heterozygous parents showed a disturbed cortisol metabolism. Genetic analysis of the HSD11B2 gene from the AME patients revealed the homozygous deletion of six nucleotides in exon 2 with the resultant loss of amino acids Leu(114) and Glu(115), representing the first alteration found in the cofactor-binding domain. The deletion mutant, expressed in HEK-293 cells, showed an approximately 20-fold lower maximum velocity but increased apparent affinity for cortisol and corticosterone. In contrast, two additionally constructed substitutions, Glu(115) to Gln or Lys, showed increased maximal velocity and apparent affinity for 11beta-hydroxyglucocorticoids. Functional analysis of wild-type and mutant proteins indicated that a disturbed conformation of the cofactor-binding domain, but not the missing negative charge of Glu(115), led to the observed decreased activity of the deletion mutant. Considered together, these findings provide evidence for a role of Glu(115) in determining cofactor-binding specificity of 11betaHSD2 and emphasize the importance of structure-function analysis to elucidate the molecular mechanism of AME.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man
Palermo, M., Shackleton, C. H. L., Mantero, F., & Stewart, P. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00853.x · Cited by 276
Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research
Shackleton, C. H. L. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90132-g · Cited by 247 · cited 3×
“Urine samples were analyzed by gas chromatography-mass spectrometry using a method similar to that described by Shackleton (13).”
MethodInfluentialOdermatt, A., Arnold, P., Stauffer, A., Frey, B. M., & Frey, F. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28762 · Cited by 190 · cited 3×
“DNA construct in the expression plasmid pcDNA3, containing an engineered Kozak consensus sequence 59 to the initiator ATG codon and a FLAG epitope tag for facilitated detection at the 39-end, was used ( 17 ).”
MethodInfluentialSelf-citationSawicki, M. W., Erman, M., Puranen, T., Vihko, P., & Ghosh, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.840 · Cited by 113
Cited by
11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
(2007) · doi:10.1139/h06-102 · Cited by 160
Apparent mineralocorticoid excess
Wilson, R. C., Nimkarn, S., & New, M. I. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00356-8 · Cited by 75
Sherbet, D. P., Guryev, O. L., Papari-Zareei, M., Mizrachi, D., Rambally, S., Akbar, S., & Auchus, R. J. (2009) · Endocrinology · doi:10.1210/en.2008-1817 · Cited by 22
Metadata
- Authors
- Odermatt, A., Dick, B., Arnold, P., Zaehner, T., Plueschke, V., Deregibus, M. N., Repetto, H., Frey, B. M., Frey, F. J., & Ferrari, P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-03
- Volume
- 86
- Issue
- 3
- Pages
- 1247-1252
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2029656830
- Cited by
- 47
- References
- 6
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Mutation in the Cofactor-Binding Domain of 11β-Hydroxysteroid Dehydrogenase Type 2 Associated with Mineralocorticoid Hypertension1. https://app.cochat.ai/papers/10.1210/jcem.86.3.7334
- The paper
- Odermatt, A., Dick, B., Arnold, P., Zaehner, T., Plueschke, V., Deregibus, M. N., Repetto, H., Frey, B. M., Frey, F. J., & Ferrari, P. (2001). A Mutation in the Cofactor-Binding Domain of 11β-Hydroxysteroid Dehydrogenase Type 2 Associated with Mineralocorticoid Hypertension1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.86.3.7334
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.